Results 231 to 240 of about 2,697,911 (252)
Some of the next articles are maybe not open access.
Clinical Therapeutics, 2019
PURPOSE β-Thalassemia is an inherited blood disorder characterized by reduced or no production of adult hemoglobin. Systematic identification of the burden of β-thalassemia with contemporary treatments is lacking in published literature.
M. Betts +5 more
semanticscholar +1 more source
PURPOSE β-Thalassemia is an inherited blood disorder characterized by reduced or no production of adult hemoglobin. Systematic identification of the burden of β-thalassemia with contemporary treatments is lacking in published literature.
M. Betts +5 more
semanticscholar +1 more source
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.
New England Journal of Medicine, 2021H. Frangoul, Tony Ho, S. Corbacioglu
semanticscholar +1 more source
Clinical Classification, Screening and Diagnosis for Thalassemia
Hematology/Oncology Clinics of North America, 2018Chayamon Takpradit +1 more
exaly
Iron-Chelating Therapy and the Treatment of Thalassemia
Blood, 1997Nancy Fern Olivieri +2 more
exaly
Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major
Circulation, 2009D J Pennell, J B Porter, J B Porter
exaly
Concomitant Inheritance of α-Thalassemia in β°-Thalassemia/Hb e Disease
American Journal of Hematology, 1985Suthat Fucharoen +2 more
exaly